Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 4
2016 1
2017 3
2018 7
2019 5
2020 12
2021 5
2022 10
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hu yao huang (36 results)?
Clinical development of mRNA therapies against solid tumors.
Wu D, Hu L, Wang X, Yu Y, Jia SP, Huang HY, Li ZW, Ma JF, Zhu HB, Tang Y, Li N. Wu D, et al. J Hematol Oncol. 2023 Jul 18;16(1):75. doi: 10.1186/s13045-023-01457-x. J Hematol Oncol. 2023. PMID: 37464375 Free PMC article.
Landscape and progress of global COVID-19 vaccine development.
Huang HY, Wang SH, Tang Y, Sheng W, Zuo CJ, Wu DW, Fang H, Du Q, Li N. Huang HY, et al. Hum Vaccin Immunother. 2021 Oct 3;17(10):3276-3280. doi: 10.1080/21645515.2021.1945901. Epub 2021 Jul 13. Hum Vaccin Immunother. 2021. PMID: 34254894 Free PMC article. Review.
Rare tumors: a blue ocean of investigation.
Wang S, Ma P, Jiang N, Jiang Y, Yu Y, Fang Y, Miao H, Huang H, Tang Q, Cui D, Fang H, Zhang H, Fan Q, Wang Y, Liu G, Yu Z, Lei Q, Li N. Wang S, et al. Among authors: huang h. Front Med. 2023 Apr;17(2):220-230. doi: 10.1007/s11684-023-0984-z. Epub 2023 Apr 26. Front Med. 2023. PMID: 37185946 Review.
Clinical development of immuno-oncology in China.
Wu DW, Huang HY, Tang Y, Zhao Y, Yang ZM, Wang J, Wang SH, Yu Y, Fang Y, Fang H, Bai Y, Sun C, Fan Q, Yu AQ, Wang HL, Du CX, Chen K, Huang MD, Zhang Y, Li N, Xu BH, Sun Y, He J. Wu DW, et al. Lancet Oncol. 2020 Aug;21(8):1013-1016. doi: 10.1016/S1470-2045(20)30329-6. Lancet Oncol. 2020. PMID: 32758460 No abstract available.
Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials.
Wang S, Yang Y, Ma P, Huang H, Tang Q, Miao H, Fang Y, Jiang N, Li Y, Zhu Q, Tao W, Zha Y, Li N. Wang S, et al. Among authors: huang h. Mol Ther Oncolytics. 2022 Feb 22;24:799-813. doi: 10.1016/j.omto.2022.02.019. eCollection 2022 Mar 17. Mol Ther Oncolytics. 2022. PMID: 35317518 Free PMC article. Review.
Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial : A randomized clinical trial of neoadjuvant therapy for ESCC.
Li Y, Zhou A, Liu S, He M, Chen K, Tian Z, Li Y, Qin J, Wang Z, Chen H, Tian H, Yu Y, Qu W, Xue L, He S, Wang S, Bie F, Bai G, Zhou B, Yang Z, Huang H, Fang Y, Li B, Dai X, Gao S, He J. Li Y, et al. Among authors: huang h. BMC Med. 2023 Mar 8;21(1):86. doi: 10.1186/s12916-023-02804-y. BMC Med. 2023. PMID: 36882775 Free PMC article. Clinical Trial.
Unveiling quality of clinical trial in China: from concern to confirmation.
Huang H, Hou Y, Fang H, Xu L, Yu Y, Zhang H, Zhang J, Tang Y, Lan G, Zhang W, Li N. Huang H, et al. Cancer Commun (Lond). 2024 May;44(5):576-579. doi: 10.1002/cac2.12528. Epub 2024 Mar 6. Cancer Commun (Lond). 2024. PMID: 38446523 Free PMC article. No abstract available.
Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review.
Huang HY, Liu CC, Yu Y, Wang L, Wu DW, Guo LW, Wang SH, Fang H, Bai Y, Fang Y, Fan Q, Sun C, Wu Y, Shi JF, Ma F, Tang Y, Dai M, Li N. Huang HY, et al. Front Pharmacol. 2020 Nov 12;11:572569. doi: 10.3389/fphar.2020.572569. eCollection 2020. Front Pharmacol. 2020. PMID: 33536905 Free PMC article. Review.
59 results